Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity

Anat Levit Kaplan, Danielle N. Confair, Kuglae Kim, Ximena Barros-Álvarez, Ramona M. Rodriguiz, Ying Yang, Oh Sang Kweon, Tao Che, John D. McCorvy, David N. Kamber, James P. Phelan, Luan Carvalho Martins, Vladimir M. Pogorelov, Jeffrey F. DiBerto, Samuel T. Slocum, Xi Ping Huang, Jain Manish Kumar, Michael J. Robertson, Ouliana Panova, Alpay B. SevenAutumn Q. Wetsel, William C. Wetsel, John J. Irwin, Georgios Skiniotis, Brian K. Shoichet, Bryan L. Roth, Jonathan A. Ellman

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

There is considerable interest in screening ultralarge chemical libraries for ligand discovery, both empirically and computationally1–4. Efforts have focused on readily synthesizable molecules, inevitably leaving many chemotypes unexplored. Here we investigate structure-based docking of a bespoke virtual library of tetrahydropyridines—a scaffold that is poorly sampled by a general billion-molecule virtual library but is well suited to many aminergic G-protein-coupled receptors. Using three inputs, each with diverse available derivatives, a one pot C–H alkenylation, electrocyclization and reduction provides the tetrahydropyridine core with up to six sites of derivatization5–7. Docking a virtual library of 75 million tetrahydropyridines against a model of the serotonin 5-HT2A receptor (5-HT2AR) led to the synthesis and testing of 17 initial molecules. Four of these molecules had low-micromolar activities against either the 5-HT2A or the 5-HT2B receptors. Structure-based optimization led to the 5-HT2AR agonists (R)-69 and (R)-70, with half-maximal effective concentration values of 41 nM and 110 nM, respectively, and unusual signalling kinetics that differ from psychedelic 5-HT2AR agonists. Cryo-electron microscopy structural analysis confirmed the predicted binding mode to 5-HT2AR. The favourable physical properties of these new agonists conferred high brain permeability, enabling mouse behavioural assays. Notably, neither had psychedelic activity, in contrast to classic 5-HT2AR agonists, whereas both had potent antidepressant activity in mouse models and had the same efficacy as antidepressants such as fluoxetine at as low as 1/40th of the dose. Prospects for using bespoke virtual libraries to sample pharmacologically relevant chemical space will be considered.

Original languageEnglish
Pages (from-to)582-591
Number of pages10
JournalNature
Volume610
Issue number7932
DOIs
Publication statusPublished - 2022 Oct 20

Bibliographical note

Funding Information:
We thank the staff at the Schrödinger for donating its Maestro and FEP+ packages and programs and OpenEye Scientific for donating the Omega and OEChem programs; E. Montabana for support with data collection; M. Huffstickler, C. Ritter and C. Means for helping with the behavioural testing; and J. Zhou for breeding, genotyping and maintaining the VMAT2 mice; and the staff at the NIDA Drug Supply Program for providing us with (+)-LSD-(+)-tartrate and psilocin. This work was supported by DARPA HR001119S0092 (to B.L.R., G.S., W.C.W. and B.K.S.) and by NIH grants R35GM122473 (to J.A.E.), R35GM122481 (to B.K.S.), R37DA045657 (to B.L.R.), R01MH11205 (B.L.R. and B.K.S.) and GM71896 (to J.J.I.). Some of the behavioural experiments were conducted with equipment and software purchased with a North Carolina Biotechnology Center grant. The views, opinions and/or findings contained in this material are those of the authors and should not be interpreted as representing the official views, policies or endorsement of the Department of Defense or the US Government.

Funding Information:
We thank the staff at the Schrödinger for donating its Maestro and FEP+ packages and programs and OpenEye Scientific for donating the Omega and OEChem programs; E. Montabana for support with data collection; M. Huffstickler, C. Ritter and C. Means for helping with the behavioural testing; and J. Zhou for breeding, genotyping and maintaining the VMAT2 mice; and the staff at the NIDA Drug Supply Program for providing us with (+)-LSD-(+)-tartrate and psilocin. This work was supported by DARPA HR001119S0092 (to B.L.R., G.S., W.C.W. and B.K.S.) and by NIH grants R35GM122473 (to J.A.E.), R35GM122481 (to B.K.S.), R37DA045657 (to B.L.R.), R01MH11205 (B.L.R. and B.K.S.) and GM71896 (to J.J.I.). Some of the behavioural experiments were conducted with equipment and software purchased with a North Carolina Biotechnology Center grant. The views, opinions and/or findings contained in this material are those of the authors and should not be interpreted as representing the official views, policies or endorsement of the Department of Defense or the US Government.

Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature Limited.

All Science Journal Classification (ASJC) codes

  • General

Fingerprint

Dive into the research topics of 'Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity'. Together they form a unique fingerprint.

Cite this